STAINES, England, January 20 /PRNewswire/ -- In response to the earthquake in Haiti the Astellas European Foundation (AEF) has announced that it is providing financial support to the International Health Partners (IHP) to help supply donated medicines for use in the devastated country. The donation will aid the provision of medicines to NGOs (non-governmental organisations) and government-run clinics and hospitals in the areas most affected in and around Port-au-Prince, the capital of Haiti.
The AEF is committed to respond to major global catastrophes with humanitarian aid and disaster relief support. This donation strengthens the AEF's relationship with IHP following a donation made last year for the supply of comprehensive portable packs. Each pack contains 45 different medicines and contributed towards the treatment of up to 1,000 children and adults in health clinics and hospitals in Eastern Europe and Africa.
IHP, established in 2004, is a charitable organisation which aims to provide free medical aid to the world's most needy people. It brings together five different stakeholder groups: government, the medical community, the pharmaceutical industry, non-governmental organisations (NGOs) and corporate social responsibility partners, making it an entirely new kind of public-private partnership.
Astellas Pharma Inc. and Astellas Pharma US Inc. have also contributed to the Haiti appeal via donations to the Japanese Red Cross and the American Red Cross.
Notes to Editors
About The Astellas European Foundation
The Astellas European Foundation is a registered charity, formed in 2005, with the long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society. In line with this aim, in 2007 and 2008 the AEF made significant donations to the global charity Save the Children. This funding provided the resources to treat more than 35,000 children with measles in Liberia and to help prevent others from contracting the disease. The Astellas European Foundation also supports Astellas employees in their private fundraising efforts for charitable causes. The AEF is supported through funding from Astellas Pharma Inc.
About Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organisation is committed to becoming a global company by combining outstanding RD and marketing capabilities and continuing to grow in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 20 affiliate offices located across Europe, the Middle East and Africa, an RD site and three manufacturing plants with approximately 3,400 staff.
SOURCE: Astellas Pharma Europe Limited
CONTACT: For more information please contact: Mindy Dooa, Director ofCorporate Communications, Astellas Pharma Europe, +44-(0)1784-419-480,Mindy.email@example.com